Commonwealth Equity Services’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$43.5M Sell
107,317
-6,631
-6% -$2.69M 0.06% 326
2025
Q1
$56.7M Buy
113,948
+4,199
+4% +$2.09M 0.08% 247
2024
Q4
$57.1M Buy
109,749
+2,478
+2% +$1.29M 0.08% 224
2024
Q3
$66.4M Sell
107,271
-6,118
-5% -$3.78M 0.1% 197
2024
Q2
$62.7M Buy
113,389
+984
+0.9% +$544K 0.1% 188
2024
Q1
$65.3M Buy
112,405
+7,620
+7% +$4.43M 0.11% 174
2023
Q4
$55.6M Buy
104,785
+5,082
+5% +$2.7M 0.1% 192
2023
Q3
$50.5M Buy
99,703
+835
+0.8% +$423K 0.1% 182
2023
Q2
$51.6M Buy
98,868
+11,131
+13% +$5.81M 0.1% 185
2023
Q1
$50.6K Sell
87,737
-3,616
-4% -$2.08K 0.11% 177
2022
Q4
$50.3M Buy
91,353
+1,733
+2% +$954K 0.12% 165
2022
Q3
$45.5M Buy
89,620
+645
+0.7% +$327K 0.12% 165
2022
Q2
$48.3M Sell
88,975
-401
-0.4% -$218K 0.13% 161
2022
Q1
$52.8M Buy
89,376
+1,473
+2% +$870K 0.12% 165
2021
Q4
$58.7M Sell
87,903
-842
-0.9% -$562K 0.13% 154
2021
Q3
$50.7M Buy
88,745
+3,048
+4% +$1.74M 0.13% 161
2021
Q2
$43.2M Buy
85,697
+7,436
+10% +$3.75M 0.11% 186
2021
Q1
$35.7M Sell
78,261
-9,203
-11% -$4.2M 0.1% 209
2020
Q4
$40.7M Buy
87,464
+7,440
+9% +$3.47M 0.12% 174
2020
Q3
$35.3M Buy
80,024
+499
+0.6% +$220K 0.12% 178
2020
Q2
$28.8M Buy
79,525
+10,263
+15% +$3.72M 0.11% 190
2020
Q1
$19.6M Buy
69,262
+1,562
+2% +$443K 0.09% 214
2019
Q4
$22M Buy
67,700
+5,125
+8% +$1.66M 0.08% 225
2019
Q3
$18.2M Buy
62,575
+3,065
+5% +$893K 0.08% 249
2019
Q2
$17.5M Buy
59,510
+5,461
+10% +$1.6M 0.08% 250
2019
Q1
$14.8M Buy
54,049
+4,396
+9% +$1.2M 0.07% 278
2018
Q4
$11.1M Buy
49,653
+1,802
+4% +$403K 0.06% 302
2018
Q3
$11.7M Buy
47,851
+6,516
+16% +$1.59M 0.06% 300
2018
Q2
$8.56M Buy
41,335
+2,882
+7% +$597K 0.04% 352
2018
Q1
$7.94M Sell
38,453
-1,723
-4% -$356K 0.04% 348
2017
Q4
$7.63M Buy
40,176
+4,137
+11% +$786K 0.04% 363
2017
Q3
$6.82M Buy
36,039
+1,576
+5% +$298K 0.04% 362
2017
Q2
$6.01M Sell
34,463
-3,976
-10% -$694K 0.04% 376
2017
Q1
$5.9M Buy
38,439
+2,620
+7% +$402K 0.04% 373
2016
Q4
$5.05M Buy
35,819
+3,891
+12% +$549K 0.04% 380
2016
Q3
$5.08M Buy
31,928
+4,307
+16% +$685K 0.04% 359
2016
Q2
$4.08M Buy
27,621
+1,132
+4% +$167K 0.03% 416
2016
Q1
$3.75M Buy
26,489
+1,892
+8% +$268K 0.03% 430
2015
Q4
$3.49M Sell
24,597
-975
-4% -$138K 0.03% 438
2015
Q3
$3.13M Buy
25,572
+1,088
+4% +$133K 0.03% 450
2015
Q2
$3.18M Buy
24,484
+333
+1% +$43.2K 0.03% 464
2015
Q1
$3.24M Buy
24,151
+1,205
+5% +$162K 0.03% 447
2014
Q4
$2.88M Buy
22,946
+6
+0% +$752 0.03% 449
2014
Q3
$2.79M Sell
22,940
-5,013
-18% -$610K 0.03% 440
2014
Q2
$3.3M Buy
27,953
+953
+4% +$112K 0.04% 383
2014
Q1
$3.25M Buy
27,000
+2,708
+11% +$326K 0.04% 353
2013
Q4
$2.71M Buy
24,292
+220
+0.9% +$24.5K 0.04% 385
2013
Q3
$2.22M Buy
24,072
+3,562
+17% +$328K 0.04% 419
2013
Q2
$1.74M Buy
+20,510
New +$1.74M 0.03% 462